View in EDS

A patent review of MAT2a inhibitors (2018-2021).

Saved in:
Bibliographic Details
Title: A patent review of MAT2a inhibitors (2018-2021).
Authors: Atkinson SJ; Oncology R&D, AstraZeneca, Cambridge UK., Evans L; Oncology R&D, AstraZeneca, Cambridge UK., Scott JS; Oncology R&D, AstraZeneca, Cambridge UK.
Source: Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2022 Oct; Vol. 32 (10), pp. 1043-1053. Date of Electronic Publication: 2022 Sep 01.
Publication Type: Review; Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7674 (Electronic) Linking ISSN: 13543776 NLM ISO Abbreviation: Expert Opin Ther Pat Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36043503
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A patent review of MAT2a inhibitors (2018-2021).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Atkinson+SJ%22">Atkinson SJ</searchLink>; Oncology R&D, AstraZeneca, Cambridge UK.<br /><searchLink fieldCode="AU" term="%22Evans+L%22">Evans L</searchLink>; Oncology R&D, AstraZeneca, Cambridge UK.<br /><searchLink fieldCode="AU" term="%22Scott+JS%22">Scott JS</searchLink>; Oncology R&D, AstraZeneca, Cambridge UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229516419%22">Expert opinion on therapeutic patents</searchLink> [Expert Opin Ther Pat] 2022 Oct; Vol. 32 (10), pp. 1043-1053. <i>Date of Electronic Publication: </i>2022 Sep 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Review; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9516419 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213543776%22">13543776 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Ther Pat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36043503
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/13543776.2022.2119127
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1043
    Titles:
      – TitleFull: A patent review of MAT2a inhibitors (2018-2021).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Atkinson SJ
      – PersonEntity:
          Name:
            NameFull: Evans L
      – PersonEntity:
          Name:
            NameFull: Scott JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1744-7674
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Expert opinion on therapeutic patents
              Type: main
ResultId 1